MIRA INFORM REPORT

 

 

Report Date :

22.11.2013

 

IDENTIFICATION DETAILS

 

Name :

LIAONING SHIXING PHARMACEUTICAL & CHEMICAL CO., LTD.

 

 

Registered Office :

No. 4 Jinhu North Road, Longgang District Huludao, Liaoning Province 125003 PR

 

 

Country :

China

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

16.05.2000

 

 

Com. Reg. No.:

211400000016676

 

 

Legal Form :

Limited Liabilities Company

 

 

Line of Business :

Manufacturing and selling of chemicals.

 

 

No. of Employees :

805

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No complaints

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

China

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

CHINA - ECONOMIC OVERVIEW

 

Since the late 1970s China has moved from a closed, centrally planned system to a more market-oriented one that plays a major global role - in 2010 China became the world's largest exporter. Reforms began with the phasing out of collectivized agriculture, and expanded to include the gradual liberalization of prices, fiscal decentralization, increased autonomy for state enterprises, creation of a diversified banking system, development of stock markets, rapid growth of the private sector, and opening to foreign trade and investment. China has implemented reforms in a gradualist fashion. In recent years, China has renewed its support for state-owned enterprises in sectors it considers important to "economic security," explicitly looking to foster globally competitive national champions. After keeping its currency tightly linked to the US dollar for years, in July 2005 China revalued its currency by 2.1% against the US dollar and moved to an exchange rate system that references a basket of currencies. From mid 2005 to late 2008 cumulative appreciation of the renminbi against the US dollar was more than 20%, but the exchange rate remained virtually pegged to the dollar from the onset of the global financial crisis until June 2010, when Beijing allowed resumption of a gradual appreciation. The restructuring of the economy and resulting efficiency gains have contributed to a more than tenfold increase in GDP since 1978. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, China in 2012 stood as the second-largest economy in the world after the US, having surpassed Japan in 2001. The dollar values of China's agricultural and industrial output each exceed those of the US; China is second to the US in the value of services it produces. Still, per capita income is below the world average. The Chinese government faces numerous economic challenges, including: (a) reducing its high domestic savings rate and correspondingly low domestic demand; (b) sustaining adequate job growth for tens of millions of migrants and new entrants to the work force; (c) reducing corruption and other economic crimes; and (d) containing environmental damage and social strife related to the economy's rapid transformation. Economic development has progressed further in coastal provinces than in the interior, and by 2011 more than 250 million migrant workers and their dependents had relocated to urban areas to find work. One consequence of population control policy is that China is now one of the most rapidly aging countries in the world. Deterioration in the environment - notably air pollution, soil erosion, and the steady fall of the water table, especially in the North - is another long-term problem. China continues to lose arable land because of erosion and economic development. The Chinese government is seeking to add energy production capacity from sources other than coal and oil, focusing on nuclear and alternative energy development. In 2010-11, China faced high inflation resulting largely from its credit-fueled stimulus program. Some tightening measures appear to have controlled inflation, but GDP growth consequently slowed to under 8% for 2012. An economic slowdown in Europe contributed to China's, and is expected to further drag Chinese growth in 2013. Debt overhang from the stimulus program, particularly among local governments, and a property price bubble challenge policy makers currently. The government's 12th Five-Year Plan, adopted in March 2011, emphasizes continued economic reforms and the need to increase domestic consumption in order to make the economy less dependent on exports in the future. However, China has made only marginal progress toward these rebalancing goals

Source : CIA


Company name and address

 

LIAONING SHIXING PHARMACEUTICAL & CHEMICAL CO., LTD.

NO. 4 JINHU NORTH ROAD, LONGGANG DISTRICT

HULUDAO, LIAONING PROVINCE 125003 PR CHINA

TEL: 86 (0) 429-2200111/2202112/2200018

FAX: 86 (0) 429-2200113/2091258

 

 

EXECUTIVE SUMMARY

 

Date of Registration                      : MAY 16, 2000

REGISTRATION NO.                              : 211400000016676

LEGAL FORM                                       : Limited liabilities company

CHIEF EXECUTIVE                                : DONG GUANGLIN (LEGAL REPRESENTATIVE)

REGISTERED CAPITAL                         : CNY 66,000,000

staff                                                  : 805

BUSINESS CATEGORY                         : MANUFACTURING & TRADING

Revenue                                            : CNY 374,383,000 (AS OF DEC. 31, 2012)

EQUITIES                                             : CNY 157,765,000 (AS OF DEC. 31, 2012)

WEBSITE                                             : www.hldsxyh.cn

E-MAIL                                                 : lnsxyh_0429@126.com

PAYMENT                                            : AVERAGE

MARKET CONDITION                            : average

FINANCIAL CONDITION                         : fairly stable

OPERATIONAL TREND                          : FAIRly steady

GENERAL REPUTATION                       : average

EXCHANGE RATE                                 : CNY 6.10 = USD 1

 

 

Adopted abbreviations (as follows)

SC - Subject Company (the company inquired by you)

N/A – Not available

CNY – China Yuan Ren Min Bi


 

OPERATIONAL TREND & GENERAL REPUTATION

 

This section aims at indicating the relative positions of SC in respect of its operational trend & general reputation

 

Operational Trend:-                                             General Reputation:-

Upward                                                             Excellent

Steady                                                              Good

Fairly Steady                                                     Fairly Good

Ordinary                                                            Average

Fair                                                                   Fair

Stagnant                                                           Detrimental

Downward                                                         Not known

Not known                                                         Not yet be determined

Not yet be determined

 

LEGAL STATUS & HISTORY

 

SC was established as a limited liabilities company of PRC with State Administration of Industry & Commerce (SAIC) under registration No.: 211400000016676 on May 16, 2000.

 

SC’s Organization Code Certificate No.: 12077030-9

 

 

SC’s registered capital: CNY 66,000,000

 

SC’s paid-in capital: CNY 66,000,000

 

Registration Change Record:-

 

Date

Change of Contents

Before the change

After the change

2008-4-23

Shareholder (s) (% of Shareholding)

Dong Guanglin

99%

Dong Dawei

1%

Dong Dawei

60%

Dong Guanglin

20%

Sun Jizhi

10%

Feng Qiusheng

5%

Wang Baoqin

5%

Registered Capital

CNY 29,000,000

CNY 66,000,000

Registration No.

2114002600257

211400000016676

 

Current Co search indicates SC’s shareholders & chief executives are as follows:-

 

Name of Shareholder (s)

% of Shareholding

Dong Dawei

 

60

Dong Guanglin

 

20

Sun Jizhi

 

10

Feng Qiusheng

 

5

Wang Baoqin

 

5

 

SC’s Chief Executives:-

 

Position

Name

Legal Representative, Chairman, and General Manager

Dong Guanglin

 

 

RECENT DEVELOPMENT

 

No recent development was found during our checks at present.

 

 

SHAREHOLDER CHART & BACKGROUND

 

Name                                                              % of Shareholding

 

Dong Dawei (ID#211403197804238210)

                                                                                    60

 

Dong Guanglin                                                               20

 

Sun Jizhi (ID#21070219640802002X)                                10

 

Feng Qiusheng (ID#130229198308201415)                       5

 

Wang Baoqin (ID#210705195202208021)                         5

 

 

MANAGEMENT

 

Dong Guanglin, Legal Representative, Chairman and General Manager

-------------------------------------------------------------------------------------------------------

Gender: M

ID#211403490929801

Age: 64

Qualification: University

Working experience (s):

 

At present, working in SC as legal representative, chairman and general manager

 

 

BUSINESS OPERATION

 

SC’s registered business scope includes manufacturing and selling p-aminophenol, paranitrochlorobenzene, ortho-nitrochlorobenzene, chlorinated benzoic, phenylhydrazine, parachloroaniline, pharmaceutical intermediates, paranitrophenylhydrazine, hydrochloride, chlorobenzene hydrazine hydrochloride, acetaminophen, iron oxide red, iron oxide yellow; selling methyl-guaiacol, ethyl- guaiacol, methyl-vanillin, ethyl- vanillin and self chemical materils;  hazardous chemicals (only flammable liquid (methylbenzene, methyl alcohol & chlorinated benzenes) and corrosives (hydrogen nitrate & sodium hydroxide)) wholesaling without storage; exporting self-made products, importing technology research needed materials; consulting service.

 

 

SC is mainly engaged in manufacturing and selling chemicals.

 

SC’s products mainly include: SC’s products mainly include 2-Ethoxyphenol, Paracetamol, Para-Amino phen, P-Nitrochlorobenzene, O-Nitrochlorobenzene, etc.

 

SC offer dozens of pharmaceutical, agrochemical and dyestuff intermediate, including Ethyl-Vanillin, Ortho-Anisidine, O-Nitro anisole, 2-Ethyl Guaiacol, Para-Amino phenol, P-Nitrochlorobenzene, O-Nitrochlorobenzene, etc. The target output is Ethyl-Vanillin 1000 tons per year, Ortho-Anisidine 10000 tons per year and Ortho-Nitro anisole 15000 tons per year.

 

SC sources its materials 90% from domestic market, and 10% from overseas market, mainly Europe. SC sells 40% of its products in domestic market, and 60% to overseas market, mainly Europe and Southeast Asian market.

 

The buying terms of SC include Check, T/T, L/C and Credit of 30-60 days. The payment terms of SC include Check, T/T, L/C and Credit of 30-60 days.

 

Staff & Office:

--------------------------

SC is known to have approx. 805 staff at present.

 

SC owns an area as its operating office and factory, but the detailed information is unknown.

 

 

RELATED COMPANY

 

SC is not known to have the subsidiary at present.

 

 

PAYMENT

 

Overall payment appraisal:

( ) Excellent      ( ) Good      (X) Average      ( ) Fair      ( ) Poor      ( ) Not yet be determined

The appraisal serves as a reference to reveal SC's payments habits and ability to pay.  It is based on the 3 weighed factors: Trade payment experience (through current enquiry with SC's suppliers), our delinquent payment and our debt collection record concerning SC.

 

Trade payment experience: SC did not provide any name of trade/service suppliers and we have no other sources to conduct the enquiry at present.

 

Delinquent payment record: None in our database.

 

Debt collection record: No overdue amount owed by SC was placed to us for collection within the last 6 years.

 

 

BANKING

 

The bank information of SC is not filed in local SAIC.

 

 

FINANCIALS

 

Balance Sheet

Unit: CNY’000

As of Dec. 31, 2011

As of Dec. 31, 2012

Cash

59,683

55,299

Notes receivable

9,725

4,095

Accounts receivable

12,161

13,291

Advances to suppliers

33,812

19,814

Other receivable

2,567

743

Inventory

142,808

175,687

Deferred expenses

0

0

Other current assets

0

0

 

------------------

------------------

Current assets

260,756

268,929

Fixed assets

127,440

160,504

Construction in progress

36,725

1,055

Intangible assets

37,746

36,840

Long-term prepaid expenses

0

0

Deferred income tax assets

11,956

29,774

Other non-current assets

781

444

 

------------------

------------------

Total assets

475,404

497,546

 

=============

=============

Short-term loans

54,400

51,300

Notes payable

88,288

88,959

Accounts payable

41,911

54,378

Wages payable

586

548

Taxes payable

-4,049

300

Advances from clients

0

0

Other payable

6,942

9,296

Other current liabilities

0

0

 

------------------

------------------

Current liabilities

188,078

204,781

Non-current liabilities

135,300

135,000

 

------------------

------------------

Total liabilities

323,378

339,781

Equities

152,026

157,765

 

------------------

------------------

Total liabilities & equities

475,404

497,546

 

=============

=============

 

Income Statement

Unit: CNY’000

As of Dec. 31, 2012

Revenue

374,383

     Cost of sales

351,572

     Taxes and surcharges

69

     Sales expense

4,548

     Management expense

9,987

     Finance expense

14,546

Non-operating income

911

     Non-operating expense

0

Profit before tax

6

Less: profit tax

0

Profits

6

 


 

Important Ratios

=============

 

As of Dec. 31, 2011

As of Dec. 31, 2012

*Current ratio

1.39

1.31

*Quick ratio

0.63

0.46

*Liabilities to assets

0.68

0.68

*Net profit margin (%)

--

0.002

*Return on total assets (%)

--

0.001

*Inventory / Revenue ×365

--

172 days

*Accounts receivable / Revenue ×365

--

13 days

*Revenue / Total assets

--

0.75

*Cost of sales / Revenue

--

0.94

 

 

FINANCIAL COMMENTS

 

PROFITABILITY: AVERAGE

The revenue of SC appears fairly good in its line in 2012.

SC’s net profit margin is average in 2012.

SC’s return on total assets is average in 2012.

SC’s cost of sales is average, comparing with its revenue.

 

LIQUIDITY: AVERAGE

The current ratio of SC is maintained in a normal level in both years.

SC’s quick ratio is maintained in a fair level in both years.

The inventory of SC appears large.

The accounts receivable of SC is maintained in an average level.

SC’s short-term loans appear average.

SC’s revenue is in an average level, comparing with the size of its total assets.

 

LEVERAGE: AVERAGE

The debt ratio of SC is average in both years.

The risk for SC to go bankrupt is average.

 

Overall financial condition of the SC: Fairly Stable.

 

 

CONCLUSIONS

 

SC is considered medium-sized in its line with fairly stable financial conditions. The large amount of inventory may be a threat to SC’s financial condition.

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.89

UK Pound

1

Rs.101.14

Euro

1

Rs.84.42

 

 

INFORMATION DETAILS

 

Report Prepared by :

NIS

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.